Paul Upham | Genentech (Roche Group): How can ankle-worn sensor fusion replace subjective clinical assessments with high-fidelity digital endpoints?
04:40 - 07:38
Other snippets from this talk
Summary of the clip:
How can ankle-worn sensor fusion replace subjective clinical assessments with high-fidelity digital endpoints?
Using a multi-sensor array featuring gyroscopes, magnetometers, and accelerometers, researchers can continuously measure a patient's stride velocity outside the clinic. Historically, walking ability was measured subjectively by clinicians watching a patient walk in a room. This wearable solution shifts the paradigm to high-fidelity, continuous monitoring in real-world environments.
This technical milestone represents one of the first digital measures officially approved by the European Medicines Agency (EMA). By measuring the exact forward velocity of the ankle and foot, drug developers can quantitatively monitor neuromuscular conditions like multiple sclerosis, Parkinson's, and Duchenne's muscular dystrophy.
The strategic advantage lies in shifting from discrete, bi-annual clinical visits to 24/7 continuous data collection. Continuous real-world monitoring dramatically improves statistical power and data fidelity for assessing therapeutic safety and efficacy.
In this short video, you can learn:
* How sensor fusion using accelerometers, gyroscopes, and magnetometers tracks stride velocity.
* Why continuous real-world digital measurements outclass subjective visual clinical tests.
* The regulatory significance of obtaining European Medicines Agency (EMA) qualification for digital endpoints.
๐ **Clip Abstract** This clip details Genentech's EMA-approved ankle-worn sensor system designed to track stride velocity in patients with neuromuscular disorders. It demonstrates how continuous, objective data collected at home replaces subjective, point-in-time clinical observations.
๐ Link in comments ๐
#SensorFusion, #StrideVelocity, #DigitalEndpoints, #AnkleWearables, #DigitalBiomarkers, #RemotePatientMonitoring
This is a highlight of the presentation:
Wearables in Pharma
Future of Electronics RESHAPED USA 2026
10-11 June 2026
Computer History Museum, Mountain View, California, USA
Organised By:
TechBlick
More Highlights from the same talk.
12:05 - 14:05
What is the rigorous validation framework required to qualify digital health sensors for clinical trials?
What is the rigorous validation framework required to qualify digital health sensors for clinical trials?
Deploying a wearable sensor in clinical trials requires navigating a highly structured verification and validation process known as the V3 framework. Before any data can support regulatory drug submissions, developers must ensure the core hardware performs to strict design specifications. This baseline technical verification is critical to guaranteeing sensor reliability.
Beyond hardware performance, developers must conduct usability validation to ensure patients can operate the technology without introducing errors. Concurrently, the underlying algorithms must undergo analytical validation to prove they can accurately transform raw sensor streams into meaningful physical metrics.
The final stage is clinical validation, which establishes that the digital metric reliably predicts or identifies a meaningful clinical state within a specific target population. Skipping or rushing any of these distinct engineering and clinical stages risks trial failure and regulatory rejection.
In this short video, you can learn:
* The four critical stages of the V3 verification and validation framework for digital health tools.
* Why usability and analytical algorithm validation are essential to prevent data corruption.
* How clinical validation proves a sensor is measuring the correct biological or functional state.
๐ **Clip Abstract** This clip breaks down the essential verification, usability, analytical, and clinical validation steps required for qualifying wearable sensors in pharmaceutical development. It outlines the technical pathway from raw data streams to legally compliant digital endpoints.
๐ Link in comments ๐
#V3Framework, #AnalyticalValidation, #DigitalEndpoints, #UsabilityValidation, #DigitalMedicine, #WearableBiosensors
17:39 - 19:25
Where does the regulatory boundary sit between a raw data sensor and a medical device?
Where does the regulatory boundary sit between a raw data sensor and a medical device?
The transition of a consumer wearable into a regulated medical device depends fundamentally on intended use, analytic processing, and how data is displayed. A sensor capturing physiological data may exist in a gray area, but the moment algorithmic processing acts on that data to warn of a clinical conditionโsuch as atrial fibrillationโit triggers medical device classification.
From a system architecture perspective, the regulatory focus often lands on the downstream display and analytics engine rather than the raw hardware. Using the example of consumer smartwatches, specific software features receive clearance (like FDA 510k or CE marking) while leaving the base hardware unclassified for general use.
System engineers must carefully analyze their block diagrams to isolate medical device functionality. If wireless data transmission separates raw data collection from the clinical interpretation system, the data gatherer might remain a non-medical device while the display system absorbs the regulatory burden.
In this short video, you can learn:
* How software analytics and data displays can transform a consumer wearable into a regulated medical device.
* The architecture strategies to isolate medical device functionality within block diagrams.
* Why FDA and CE marking regulations target specific software capabilities over physical sensors.
๐ **Clip Abstract** This clip explains the subtle regulatory boundaries separating consumer health sensors from certified medical devices using block-diagram system architectures. It highlights how algorithmic interpretation and data visualization drive regulatory classifications like FDA 510(k) clearance.
๐ Link in comments ๐
#SoftwareAsAMedicalDevice, #SystemArchitectureDesign, #FDA510kClearance, #WearableBiosensors, #WearableMedTech, #FlexibleElectronics